Advertisement

Urea and Derivatives as Penetration Enhancers

  • Adrian C. Williams

Abstract

Urea has long been used in topical and transdermal preparations and is variously described for its moisturising, keratolytic and penetration-enhancing activities. This chapter describes the historical use of urea in dermal products, describes the use of urea as an emollient in managing skin disorders such as atopic dermatitis and considers the literature reports of urea as a permeation enhancer. In attempts to increase the penetration enhancement activity of the molecule, several studies have reported chemical modifications of urea and the consequent accelerant activities towards permeants. Finally, considering the keratolytic properties of urea and, in several products, its long-term use, the chapter closes with a discussion of the safety of the molecule and its regulatory status.

Keywords

Urea Urea derivatives Carbamide Enhancer Emollient Hydrotrope Safety 

References

  1. Alberti I, Kalia YN, Naik A, Bonny JD, Guy RH (2001) In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J Control Release 71:319–327CrossRefPubMedGoogle Scholar
  2. Amgaokar YM, Chikhale RV, Lade UB, Biyani DM, Umekar MJ (2011) Design, formulation and evaluation of transdermal drug delivery system of budesonide. Dig J Nanomater Biostruct 6:475–497Google Scholar
  3. Ammar HO, Salama HA, Ghorab M, El-Nahhas SA, Elmotasem H (2006) A transdermal delivery system for glipizide. Curr Drug Deliv 3:333–341CrossRefPubMedGoogle Scholar
  4. Andersen FA (2005) Final report of the safety assessment of urea. Int J Toxicol 24:1–56Google Scholar
  5. Aungst BJ, Roger NJ, Shefter E (1986) Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulphoxides and amides. Int J Pharm 33:225–234CrossRefGoogle Scholar
  6. Barry BW, Woodford R (1976) Proprietary hydrocortisone creams: vasoconstrictor activities and bio-availabilities of six preparations. Br J Dermatol 95:423–425CrossRefPubMedGoogle Scholar
  7. Beastall J, Guy RH, Hadgraft J, Wilding I (1986) The influence of urea on percutaneous absorption. Pharm Res 3:294–297CrossRefPubMedGoogle Scholar
  8. Bentley MVLB, Kedor ERM, Vianna RF, Collett JH (1997) The influence of lecithin and urea on the in vitro permeation of hydrocortisone acetate through skin from hairless mouse. Int J Pharm 146:255–262CrossRefGoogle Scholar
  9. Bettinger J, Maibach HI (1997) SC water-binding capacity. Cosmet Toiletries 112:49–53Google Scholar
  10. Bettinger J, Gloor M, Gehring W, Wolf W (1995) Influence of emulsions with and without urea on water-binding capacity of stratum corneum. J Soc Cosmet Chem 46:247–254Google Scholar
  11. Brand RM, Charron AR, Sandler VL, Jendrzejewski JL (2007) Moisturising lotions can increase transdermal absorption of the herbicide 2,4-dichlorophenoxacetic acid across hairless mouse skin. Cutan Ocul Toxicol 26:15–23CrossRefPubMedGoogle Scholar
  12. British National Formulary (2012) 63. Section 13, Pharmaceutical Press, LondonGoogle Scholar
  13. Buyuktimkin S, Buyutimkin N, Rytting RH (1993) Synthesis and enhancing effect of dodecyl 2-(N, N-dimethylamino)propionate on the transepidermal delivery of indomethacin, clonidine and hydrocortisone. Pharm Res 10:1632–1637CrossRefPubMedGoogle Scholar
  14. Chi SC, Park ES, Kim H (1995) Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm 126:267–274CrossRefGoogle Scholar
  15. Cler EJ, Fourtanier A (1981) L’acide pyrrolidone carboxylique (PCA) et la peau. Intl J Cosmet Sci 3:101–113CrossRefGoogle Scholar
  16. do Couto SG, Oliverira MD, Alonso A (2005) Dynamics of proteins and lipids in the stratum corneum: effects of percutaneous permeation enhancers. Biophys Chem 116:23–31CrossRefPubMedGoogle Scholar
  17. Feldman R, Maibach HI (1974) Percutaneous penetration of hydrocortisone with urea. Arch Dermatol 109:58–59CrossRefGoogle Scholar
  18. Ferrante M, Andreeta A, Landoni MF (2010) Effect of different penetration enhancers on diclofenac permeation across horse skin. Vet J 186:312–315CrossRefPubMedGoogle Scholar
  19. Gardner M (1999) Urine therapy. Skeptical Inquirer 23(3):13–15Google Scholar
  20. Gloor M, Fluhr J, Wasik B, Gehring W (2001) Clinical effect of salicylic acid and high dose urea applied in standardized NRF formulations. Pharmazie 56:810–814PubMedGoogle Scholar
  21. Godwin DA, Player MR, Sowell JR, Michniak BB (1998) Synthesis and investigation of urea compounds as transdermal penetration enhancers. Int J Pharm 167:165–175CrossRefGoogle Scholar
  22. Grice K, Sattar H, Baker H (1973) Urea and retinoic acid in ichthyosis and their effect on transepidermal water loss and water holding capacity of stratum corneum. Acta Dermato 53:114–118Google Scholar
  23. Han SK, Park YH, Kim CK (1995) Preparation of N-adamantyl n-alkylamides and evaluation of their transdermal penetration in the rabbit. Int J Pharm 126:35–40CrossRefGoogle Scholar
  24. Hellgren L, Larsson K (1974) On the effects of urea on human epidermis. Dermatologica 149:289–293CrossRefPubMedGoogle Scholar
  25. Higuchi T, Pogany SA (1987) Cyclic ureas as dermal penetration enhancers. US Patent 4,677,131Google Scholar
  26. Horii Y, Tanida M, Shen J, Fujisaki Y, Fuyuki R, Hashimoto K, Niijima A, Nakashima T, Nagai K (2011) Skin application of urea-containing cream affected cutaneous arterial sympathetic nerve activity, blood flow and water evaporation. Skin Res Tech 17:75–81CrossRefGoogle Scholar
  27. Hrabalek A, Dolezal P, Krebs A, Farsa O, Sklubalova Z (1997) Urea derivatives as transdermal penetration enhancers. Chemicke Listy 91:682–683Google Scholar
  28. Kim CK, Kim JJ, Chi SC, Shim CK (1993) Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int J Pharm 99:109–118CrossRefGoogle Scholar
  29. Labouta HI, El-Khordagui LK, Schneider M (2012) Could chemical enhancement of gold nanoparticle penetration be extrapolated from established approaches for drug permeation? Skin Pharm Physiol 25:208–218CrossRefGoogle Scholar
  30. Loden M (1996) Urea-containing moisturisers influence barrier properties of normal skin. Arch Dermatol Res 288:103–107CrossRefPubMedGoogle Scholar
  31. Loden M, Bostrom P, Kneczke M (1995) Distribution and keratolytic effect of salicylic acid and urea in human skin. Skin Pharmacol 8:173–178CrossRefPubMedGoogle Scholar
  32. Loden M, Anderson AC, Lindberg M (1999) Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturising cream (Canoderm). Br J Dermatol 140:264–268CrossRefPubMedGoogle Scholar
  33. Lu MYF, Lee D, Rao GS (1992) Percutaneous absorption enhancement of leuprolide. Pharm Res 9:1575–1579CrossRefPubMedGoogle Scholar
  34. Niazy EM (1991) Influence of oleic acid and other permeation promoters on transdermal delivery of dihydroergotamine through rabbit skin. Int J Pharm 67:97–100CrossRefGoogle Scholar
  35. Nishihata T, Rytting JH, Kamada A, Matsumoto K, Takahashi K (1990) Combined effect of alcohol and urea on the in vitro transport of indomethacin across rat dorsal skin. J Pharm Sci 79:487–489CrossRefPubMedGoogle Scholar
  36. Rawlings AV, Hardy CR (2004) Moisturization and skin barrier function. Dermatol Ther 17:43–48CrossRefPubMedGoogle Scholar
  37. Rezus YLA, Bakker HJ (2006) Effect of urea on the structural dynamics of water. Proc Natl Acad Sci U S A 103:18417–18420PubMedCentralCrossRefPubMedGoogle Scholar
  38. Sammeta SM, Repka MA, Murthy SN (2011) Magnetophoresis in combination with chemical enhancers for transdermal drug delivery. Drug Dev Ind Pharm 37:1076–1082CrossRefPubMedGoogle Scholar
  39. Savic S, Tamburic S, Savic M, Cekic N, Milic J, Vuleta G (2004) Vehicle-controlled effect of urea on normal and SLS-irritated skin. Int J Pharm 271:269–280CrossRefPubMedGoogle Scholar
  40. Sogias IA, Khutoryanskiy VV, Williams AC (2010) Exploring the factors affecting the solubility of chitosan in water. Macromol Chem Phys 211:426–433CrossRefGoogle Scholar
  41. Soper AK, Castner EW, Luzar A (2003) Impact of urea on water structure: a clue to its properties as a denaturant? Biophys Chem 105:649–666CrossRefPubMedGoogle Scholar
  42. Sznitowska M, Janicki S, Gos T (1996) The effect of sorption promoters on percutaneous permeation of a model zwitterion – Baclofen. Int J Pharm 137:125–132CrossRefGoogle Scholar
  43. Taylor LS, York P, Williams AC, Edwards HGM, Mehta V, Jackson GS, Badcoe IG, Clarke AR (1995) Sucrose reduces the efficiency of protein denaturation by a chaotropic agent. Biochim Biophys Acta 1253:39–46CrossRefPubMedGoogle Scholar
  44. Vaddi HK, Wang LZ, Ho PC, Chan SY (2001) Effect of some enhancers on the permeation of haloperidol through rat skin in vitro. Int J Pharm 212:247–255CrossRefPubMedGoogle Scholar
  45. Valenta C, Wedenig S (1997) Effects of penetration enhancers on the in vitro percutaneous absorption of progesterone. J Pharm Pharmacol 49:955–959CrossRefPubMedGoogle Scholar
  46. Visscher MO, Tolia GT, Wickett RR, Hoath SB (2003) Effect of soaking and natural moisturising factor on stratum corneum water-handling properties. J Cosmet Sci 54:289–300PubMedGoogle Scholar
  47. Williams AC (2003) Transdermal and topical drug delivery; from theory to clinical practice. Pharmaceutical Press, LondonGoogle Scholar
  48. Williams AC, Barry BW (1989) Urea analogues in propylene glycol as penetration enhancers in human skin. Int J Pharm 56:43–50CrossRefGoogle Scholar
  49. Wohlrab W (1984) The influence of urea on the penetration kinetics of topically applied corticosteroids. Acta Dermato-Vener 64:233–238Google Scholar
  50. Wong O, Huntington J, Konishi R, Rytting JH, Higuchi T (1988) Unsaturated cyclic ureas as new nontoxic biodegradable transdermal penetration enhancers. 1. Synthesis. J Pharm Sci 77:967–971CrossRefPubMedGoogle Scholar
  51. Wong O, Tsuzuki N, Nghiem B, Kuehnhoff J, Itoh T, Masaki K, Huntingdon J, Konishi R, Rytting JH, Higuchi T (1989) Unsaturated cyclic ureas as new non-toxic biodegradable transdermal penetration enhancers. II. Evaluation study. Int J Pharm 52:191–192CrossRefGoogle Scholar
  52. Woodford R, Barry BW (1984) Alphaderm cream (1% hydrocortisone and 10% urea): investigation of vasoconstrictor activity, bioavailability and application regimens in human volunteers. Curr Ther Res 35:759–767Google Scholar
  53. Zbytovska J, Vavrova K, Kiselev MA, Lessieur P, Wartewig S, Neubert RHH (2009) The effects of transdermal permeation enhancers on thermotropic phase behaviour of a stratum corneum lipid model. Colloids Surf A Physicochem Eng Asp 351:30–37CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of PharmaceuticsSchool of Pharmacy, University of ReadingReadingUK

Personalised recommendations